Cognitive enhancing effect of the fermented Gumiganghwal-tang on scopolamine-induced memory impairment in mice

Nutr Neurosci. 2016;19(3):125-30. doi: 10.1179/1476830514Y.0000000152. Epub 2014 Sep 12.

Abstract

Gumiganghwal-tang (GT) is a traditional herbal medicine that is widely used for its anti-inflammatory, analgesic, and antipyretic actions. Fermented GT has been reported to inhibit acetylcholinesterase (AChE) activity and to exert a neuroprotective effect. In this study, we investigated the effect of fermented GT against scopolamine-induced memory impairment in mice using the Morris water maze and passive avoidance tests. The results of the Morris water maze test indicated that fermented GT significantly decreased escape latency, as compared with that observed in the scopolamine-treated group. In the prove test, fermented GT attenuated the decreased time spent in the target quadrant observed after scopolamine treatment. The results of the passive avoidance test indicated that the treatment with fermented GT increased latency time when compared with the scopolamine-treated group. Moreover, fermented GT inhibited AChE activity in the hippocampi of the treated mice. These results suggest that fermented GT reduced scopolamine-induced amnesia in mice through AChE inhibition. Therefore, we hypothesize that fermented GT may be a useful therapeutic agent for the prevention or treatment of neurodegenerative diseases.

Keywords: Acetylcholinesterase; Cognitive-enhancing effect; Fermented Gumiganghwal-tang; Morris water maze test; Passive avoidance test.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcholinesterase / metabolism
  • Animals
  • Avoidance Learning / drug effects
  • Behavior, Animal / drug effects
  • Cholinergic Antagonists / toxicity
  • Cholinesterase Inhibitors / administration & dosage
  • Cholinesterase Inhibitors / therapeutic use*
  • Dietary Supplements*
  • Disease Models, Animal*
  • Donepezil
  • Fermentation
  • GPI-Linked Proteins / antagonists & inhibitors
  • GPI-Linked Proteins / metabolism
  • Hippocampus / drug effects
  • Hippocampus / enzymology
  • Indans / therapeutic use
  • Male
  • Maze Learning / drug effects
  • Memory Disorders / chemically induced
  • Memory Disorders / enzymology
  • Memory Disorders / prevention & control*
  • Mice, Inbred ICR
  • Muscarinic Antagonists / toxicity
  • Nerve Tissue Proteins / antagonists & inhibitors
  • Nerve Tissue Proteins / metabolism
  • Neurons / drug effects
  • Neurons / enzymology
  • Nootropic Agents / administration & dosage
  • Nootropic Agents / therapeutic use*
  • Piperidines / therapeutic use
  • Plant Extracts / administration & dosage
  • Plant Extracts / therapeutic use*
  • Republic of Korea
  • Scopolamine / toxicity

Substances

  • Cholinergic Antagonists
  • Cholinesterase Inhibitors
  • GPI-Linked Proteins
  • Indans
  • Muscarinic Antagonists
  • Nerve Tissue Proteins
  • Nootropic Agents
  • Piperidines
  • Plant Extracts
  • kumi-kyokatsu-to
  • Donepezil
  • Scopolamine
  • Acetylcholinesterase
  • Ache protein, mouse